# Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)

The National Institute on Deafness and other Communication Disorders (NIDCD) intends to re-issue a Notice of Funding Opportunity (NOFO, prior funding opportunity RFA-DC-24-008 to solicit applications for research on early-stage dissemination and implementation (D&I) in the NIDCD mission areas of hearing, balance, taste, smell, voice, speech, and language. Much research is devoted to developing evidence-based innovations (EBIs) that improve a person"s health and quality of life. To impact people"s lives, EBIs need to be adopted in clinical practice and everyday life. Unfortunately, wide-scale adoption of EBIs is lengthy and rare. Dissemination and implementation (D&I) science is the field of...

Canonical page: https://grantsonar.com/grants/opportunity/early-stage-dissemination-and-implementation-research-in-communication-d-7d7b2185-e785-43a9-a8a5-ec9d02618722
Source: grants_gov
Source ID: 359274
Last confirmed Oct 13, 2026 · Grants.gov
Deadline: June 17, 2027
Award size: not disclosed

## Answer-first Q&A

### Who is eligible for Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) eligibility includes eligible applicants named in the notice. Geographic eligibility is national or notice-specific geography; applicants should confirm the source notice before applying.

### What is the deadline for Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) has a listed deadline of June 17, 2027. Grant deadlines can change, so verify the current date with National Institutes of Health before submitting.

### How much funding is available for Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) lists an award size of not disclosed. Award ranges and total program funding are reported from the source metadata when available.

### Who funds Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is funded by National Institutes of Health. GrantSonar tracks the notice with source ID 359274 from grants_gov.